Dave's Patent Content Factory
Applications
Terms
Paragraphs
Claims
Docket
Logout
About
Paragraph #7,391
Edit Paragraph
View
List Paragraphs
Delete
Application
2380.2.01
US-20150012794-A1
US-20150205664-A1
US-20100023800-A1
US-8737141-A1
US-10157004-B2
US10007433A1
US-9159419-B2
US-10114589-A1
US-10134728-A1
US-20200065270-A1
US-10637533-B2
US-9927986-A1
US-8380915-A1
US-9159419-A1
US-9208071-A1
US-20200098728-A1
US-10643676-A1
US-10468073-B2
US-10283200-A1
US-10461965-B1
US-20130279232-A1
US-8892980-B2
US9632727A1
US10558561A1
US20100023800A1
US7230213A1
OPT-9
FLO-2
FLO-5PROV
ONSO3175(B) - Onsemi378
ONSO3305US - Onsemi346
GTS-3DES
FLO-4
US8762658B2
US8533406B2
US9632727B2
KMN-1PROV
PAT-2
PER-8 PROV
PER-9 PROV
INS-4PROV
HAR-1
CES-16
NXT-5PROV NXT-5, 6, 7, 8
IPP-0051-US14 cross roads
FLO-7PROV
IMI-5PROV
IPP-0050-US35 nextremity
VIL-12
OPT-13
TOY-1
US10998041B1
FSP1845
US6559866B2
Placeholder App
PER-10
KBR-1 1400.2.623
PER-13PROV
PAT-3
US20030023453
RMS-1DES
SMG-1DES
FLO-5
US10318495
US10133662B2
PER-11
US20140066758
VIL-17
PER-17
JBR-1
PER-12
US11056880
US11302645
US20210407565
US11081191
PON-1PROV, 2PROV, 3PROV
PER-33
RMT-1PROV
PER-32
PER-34
MCC-1
FLO-10
PER-14
PER-19
PER-22
PER-18
PER-24
TMC-PAT-1
DAR-2
PER-23
TMC-PAT-4
PER-16
PER-4 DIV1
PER-20
PER-21
BRT-PAT-1
TMC-PAT-5
TMC-PAT-6PROV
BRT-PAT-2-PROV
71212.157.USU1
FPR-PAT-1-PROV
71212.158.USP1
RMT-1
DAR-1PROV
DAR-2PROV
PON-1PROV
PON-2PROV
PON-3PROV
PER-18PROV
TMC-1PROV
TMC-2PROV
PER-13PCT
PER-13
PER-16PROV
PER-14PROV
PER-34PROV
TMC-4PROV
TMC-3
PAS-1PROV
VEH-1
PER-29DES
TEST.001
E2E-TEST.001
TEST-001
TEST-002
TEST-003
TEST-004
ZED006
FSP1011
GAV-PAT-1-PROV
Matter Number
Paragraph Number
75
Application Number
Reference Case 1
Reference Case 2
Content
Advantageously, the OCL 350 may have a diameter D1 that is smaller than a diameter D2 of the natural articular surface 260. In certain embodiments, the system 300 can be used to treat the OCL 350 such that a minimal amount of bone and/or soft tissue of the natural articular surface 260 is removed for the procedure.
Notes
Added by DJM 2 2022
Raw Data
<w:p w14:paraId="0C166AB9" w14:textId="77777777" w:rsidR="00350AA3" w:rsidRPr="003D626C" w:rsidRDefault="00A96179" w:rsidP="00E725D7"><w:pPr><w:pStyle w:val="NumberedParagraph"/></w:pPr><w:r w:rsidRPr="003D626C"><w:t xml:space="preserve">Advantageously, the OCL 350 </w:t></w:r><w:r w:rsidR="001C5256" w:rsidRPr="003D626C"><w:t>may have</w:t></w:r><w:r w:rsidRPr="003D626C"><w:t xml:space="preserve"> a diameter D1 that is smaller than a diameter </w:t></w:r><w:r w:rsidR="001C5256" w:rsidRPr="003D626C"><w:t xml:space="preserve">D2 </w:t></w:r><w:r w:rsidRPr="003D626C"><w:t>of the natural articular surface 260.</w:t></w:r><w:r w:rsidR="00271E5D" w:rsidRPr="003D626C"><w:t xml:space="preserve"> In certain embodiments, the </w:t></w:r><w:r w:rsidR="001C5256" w:rsidRPr="003D626C"><w:t xml:space="preserve">system 300 </w:t></w:r><w:r w:rsidR="00271E5D" w:rsidRPr="003D626C"><w:t>can be used to treat the OCL 350 such that a minimal amount of bone and/or soft tissue of the natural articular surface 260 is removed for the procedure.</w:t></w:r><w:r w:rsidR="005246B5" w:rsidRPr="003D626C"><w:t xml:space="preserve"> </w:t></w:r></w:p>
Submit